62 related articles for article (PubMed ID: 15026802)
1. Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
Brown MR; Chuaqui R; Vocke CD; Berchuck A; Middleton LP; Emmert-Buck MR; Kohn EC
Gynecol Oncol; 1999 Jul; 74(1):98-102. PubMed ID: 10385558
[TBL] [Abstract][Full Text] [Related]
2. Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.
Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
Br J Cancer; 2004 Mar; 90(6):1204-10. PubMed ID: 15026802
[TBL] [Abstract][Full Text] [Related]
3. Fractional allelic loss as a potential biomarker of risk prediction in early-stage mucinous ovarian tumors of low malignant potential.
Nakayama K; Nakayama N; Ishibashi M; Yeasmin S; Fukumoto M; Miyazaki K
Eur J Gynaecol Oncol; 2009; 30(1):16-9. PubMed ID: 19317250
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma.
Nakayama K; Takebayashi Y; Namiki T; Tamahashi N; Nakayama S; Uchida T; Miyazaki K; Fukumoto M
Int J Cancer; 2001 Nov; 94(4):605-9. PubMed ID: 11745452
[TBL] [Abstract][Full Text] [Related]
5. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
Fukumoto M; Nakayama K
Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
[TBL] [Abstract][Full Text] [Related]
8. Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy.
Nakayama S; Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Fukumoto M; Miyazaki K
Int J Mol Med; 2003 May; 11(5):621-5. PubMed ID: 12684700
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.
Nakayama K; Takebayashi Y; Nakayama S; Hata K; Fujiwaki R; Fukumoto M; Miyazaki K
Cancer Lett; 2003 Mar; 192(2):227-35. PubMed ID: 12668287
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas.
Beder LB; Gunduz M; Ouchida M; Fukushima K; Gunduz E; Ito S; Sakai A; Nagai N; Nishizaki K; Shimizu K
Lab Invest; 2003 Jan; 83(1):99-105. PubMed ID: 12533690
[TBL] [Abstract][Full Text] [Related]
11. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
12. Surgical staging in patients with ovarian tumors of low malignant potential.
Winter WE; Kucera PR; Rodgers W; McBroom JW; Olsen C; Maxwell GL
Obstet Gynecol; 2002 Oct; 100(4):671-6. PubMed ID: 12383532
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ultrasound derived intratumoral peak systolic velocity in epithelial ovarian cancer.
Hata K; Yoshida M; Maruyama R; Fujiwaki R; Miyazaki K
Ultrasound Obstet Gynecol; 2002 Aug; 20(2):186-91. PubMed ID: 12153671
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
